We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+20.94%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$612B
AUM Growth
+$90.2B
Cap. Flow
+$5B
Cap. Flow %
0.82%
Top 10 Hldgs %
32.09%
Holding
12,204
New
1,722
Increased
4,580
Reduced
4,534
Closed
1,264

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$703M
2
BAC icon
Bank of America
BAC
+$690M
3
AMZN icon
Amazon
AMZN
+$678M
4
JPM icon
JPMorgan Chase
JPM
+$601M
5
META icon
Meta Platforms (Facebook)
META
+$431M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.11%
2 Technology 2.38%
3 Consumer Discretionary 1.48%
4 Healthcare 0.92%
5 Communication Services 0.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTUS icon
10501
CALL
Metallus
MTUS
$825M
$86K ﹤0.01%
+18,500
New +$83.7K
ITI
10502
PUT
DELISTED
Iteris, Inc.
ITI
$86K ﹤0.01%
15,200
-9,000
-37% -$42.9K
APTO
10503
CALL
DELISTED
Aptose Biosciences, Inc.
APTO
$86K ﹤0.01%
+44
New +$103K
ACHV icon
10504
Achieve Life Sciences
ACHV
$842M
$85K ﹤0.01%
+10,510
New +$89K
ADMA icon
10505
CALL
ADMA Biologics
ADMA
$2.12B
$85K ﹤0.01%
43,800
-84,900
-66% -$178K
CPRX
10506
PUT
DELISTED
Catalyst Pharmaceutical
CPRX
$85K ﹤0.01%
25,500
-51,500
-67% -$173K
FENC icon
10507
Fennec Pharmaceuticals
FENC
$413M
$85K ﹤0.01%
11,368
-21,492
-65% -$164K
VNRX icon
10508
CALL
VolitionRx Ltd
VNRX
$7.23M
$85K ﹤0.01%
1,090
+180
+20% +$12.4K
AIOT
10509
CALL
PowerFleet Inc
AIOT
$403M
$85K ﹤0.01%
+11,400
New +$76.3K
TAST
10510
PUT
DELISTED
Carrols Restaurant Group, Inc.
TAST
$85K ﹤0.01%
13,500
-7,500
-36% -$47.9K
SYRE icon
10511
Spyre Therapeutics
SYRE
$8.25B
$84K ﹤0.01%
426
-23
-5% -$4.77K
VRNA
10512
DELISTED
Verona Pharma
VRNA
$84K ﹤0.01%
+12,037
New +$81.3K
NM
10513
PUT
DELISTED
Navios Maritime Holdings Inc.
NM
$84K ﹤0.01%
+37,500
New +$76K
AFMD
10514
CALL
DELISTED
Affimed
AFMD
$83K ﹤0.01%
1,420
-3,360
-70% -$158K
SMM
10515
DELISTED
Salient Midstream & MLP Fund
SMM
$83K ﹤0.01%
+19,534
New +$78.5K
AMPY icon
10516
Amplify Energy
AMPY
$195M
$82K ﹤0.01%
62,368
+31,649
+103% +$31.4K
MFIN icon
10517
PUT
Medallion Financial
MFIN
$271M
$82K ﹤0.01%
+16,700
New +$65.9K
OGI
10518
PUT
Organigram Holdings
OGI
$173M
$82K ﹤0.01%
15,425
-10,050
-39% -$51.6K
DMYD.WS
10519
DELISTED
dMY Technology Group, Inc. II Redeemable Warrants, each whole warrant exercisable for one share of C
DMYD.WS
$82K ﹤0.01%
+19,365
New +$41.2K
BPT
10520
CALL
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$81K ﹤0.01%
+34,000
New +$68.6K
CPRX
10521
CALL
DELISTED
Catalyst Pharmaceutical
CPRX
$81K ﹤0.01%
24,400
-89,800
-79% -$302K
GLRE icon
10522
CALL
Greenlight Captial
GLRE
$503M
$81K ﹤0.01%
11,100
QUAD icon
10523
Quad
QUAD
$518M
$81K ﹤0.01%
+21,261
New +$65.3K
BRY
10524
DELISTED
Berry Corp
BRY
$80K ﹤0.01%
21,744
-50,465
-70% -$174K
TMQ
10525
CALL
Trilogy Metals
TMQ
$653M
$80K ﹤0.01%
39,800
+15,300
+62% +$27.2K

Similar funds

Jeff Yass's Q4 2020 Portfolio in Review

As of Q4 2020, Jeff Yass held 12,204 positions worth $612B, up 17% from $522B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2020 filing shows 1,722 new, 4,580 increased, 4,534 reduced and 1,264 closed positions. Its largest new stake was International Flavors & Fragrances: 726,729 shares worth $79.1M. The largest sale was Citigroup, an estimated $703M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2020 buy was International Flavors & Fragrances: 726,729 shares worth $79.1M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $1.46B increase.
  • Jeff Yass's biggest Q4 2020 reduction was Citigroup, cutting an estimated $703M.
  • Jeff Yass fully exited Vanguard Total International Bond ETF in Q4 2020, selling an estimated $146M.
  • Jeff Yass's ten largest holdings make up 32% of its $612B portfolio in Q4 2020.
  • Jeff Yass opened 1,722 new positions and closed 1,264 in Q4 2020.
  • Jeff Yass's portfolio value rose 17% quarter-over-quarter to $612B.

Based on Susquehanna International Group's 13F filing for Q4 2020, filed 16 Feb 2021.